The Full Wiki

insomnia: Wikis

  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

Insomnia
Classification and external resources
ICD-10 F51.0, G47.0
ICD-9 307.42, 307.41, 780.51, 780.52
DiseasesDB 26877
eMedicine med/2698 
MeSH D007319

Insomnia is a symptom[1] of any of several sleep disorders, characterized by persistent difficulty falling asleep or staying asleep despite the opportunity. Insomnia is a symptom, not a stand-alone diagnosis or a disease. By definition, insomnia is "difficulty initiating or maintaining sleep, or both" and it may be due to inadequate quality or quantity of sleep. It is typically followed by functional impairment while awake. Both organic and non-organic insomnia without other cause constitute a sleep disorder, primary insomnia.[2]

According to the United States Department of Health and Human Services in the year 2007, approximately 64 million Americans regularly suffer from insomnia each year.[3] Insomnia is 1.4 times more common in women than in men.[4]

Contents

Types of insomnia

Although there are several different degrees of insomnia, three types of insomnia have been clearly identified: transient, acute, and chronic.

  1. Transient insomnia lasts from days to weeks. It can be caused by another disorder, by changes in the sleep environment, by the timing of sleep, severe depression, or by stress. Its consequences - sleepiness and impaired psychomotor performance - are similar to those of sleep deprivation.[5]
  2. Acute insomnia is the inability to consistently sleep well for a period of between three weeks to six months.[6]
  3. Chronic insomnia lasts for years at a time. It can be caused by another disorder, or it can be a primary disorder. Its effects can vary according to its causes. They might include sleepiness, muscular fatigue, hallucinations, and/or mental fatigue; but people with chronic insomnia often show increased alertness. Some people that live with this disorder see things as though they were happening in slow motion, whereas moving objects seem to blend together. Can cause double vision.[5]

Patterns of insomnia

The pattern of insomnia often is related to the etiology.[7] Insomnia affects 1 in 3 people.

  1. Onset insomnia - difficulty falling asleep at the beginning of the night, often associated with anxiety disorders.
  2. Middle-of-the-Night Insomnia - Insomnia characterized by difficulty returning to sleep after awakening in the middle of the night or waking too early in the morning. Also referred to as nocturnal awakenings. Encompasses middle and terminal insomnia.
  3. Middle insomnia - waking during the middle of the night, difficulty maintaining sleep. Often associated with pain disorders or medical illness.
  4. Terminal (or late) insomnia - early morning waking. Often a characteristic of clinical depression.

Causes

Insomnia can be caused by:

Sleep studies using polysomnography have suggested that people who have insomnia with sleep disruption have elevated nighttime levels of circulating cortisol and adrenocorticotropic hormone They also have an elevated metabolic rate, which does not occur in people who do not have insomnia but whose sleep is intentionally disrupted during a sleep study. Studies of brain metabolism using positron emission tomography (PET) scans indicate that people with insomnia have higher metabolic rates by night and by day. The question remains whether these changes are the causes or consequences of long-term insomnia.[11]

Insomnia can be common after the loss of a loved one, even years or decades after the death, if they have not gone through the grieving process. Overall, symptoms and the degree of their severity affect each individual differently depending on their mental health, physical condition, and attitude or personality.

A common misperception is that the amount of sleep required decreases as a person ages. The ability to sleep for long periods, rather than the need for sleep, appears to be lost as people get older. Some elderly insomniacs toss and turn in bed and occasionally fall off the bed at night, diminishing the amount of sleep they receive.[12]

Epidemiology

The National Sleep Foundation's 2002 Sleep in America poll showed that 58% of adults in the U.S. experienced symptoms of insomnia a few nights a week or more.[13] Although insomnia was the most common sleep problem among about one half of older adults (48%), they were less likely to experience frequent symptoms of insomnia than their younger counterparts (45% vs. 62%), and their symptoms were more likely to be associated with medical conditions, according to the 2003 poll of adults between the ages of 55 and 84.[13]

Diagnosis

Specialists in sleep medicine are qualified to diagnose the many different sleep disorders. Patients with various disorders including delayed sleep phase syndrome are often mis-diagnosed with insomnia.

File:Complications of
Potential complications of insomnia.[14]

If a patient has trouble getting to sleep, but has normal sleep pattern once asleep, a circadian rhythm disorder is a likely cause.

Sleep duration and mortality

A survey of 1.1 million residents in America found that those who reported sleeping about 7 hours per night had the lowest rates of mortality, whereas those who slept for fewer than 6 hours or more than 8 hours had higher mortality rates. Getting 8.5 or more hours of sleep per night increased the mortality rate by 15%. Severe insomnia - sleeping less than 3.5 hours in women and 4.5 hours in men - also led to a 15% increase in mortality. However, most of the increase in mortality from severe insomnia was discounted after controlling for comorbid disorders. After controlling for sleep duration and insomnia, use of sleeping pills was also found to be associated with an increased mortality rate. The lowest mortality was seen in individuals who slept between six and a half and seven and a half hours per night. Even sleeping only 4.5 hours per night is associated with very little increase in mortality. Thus mild to moderate insomnia for most people may actually increase longevity and severe insomnia has only a very small effect on mortality. As long as a patient refrains from using sleeping pills there is little to no increase in mortality associated with insomnia but there does appear to be an increase in longevity. This is reassuring for patients with insomnia in that despite the sometimes unpleasantness of insomnia, insomnia itself appears to be associated with increased longevity. It is unclear why sleeping longer than 7.5 hours is associated with excess mortality.[15]

Insomnia versus poor sleep quality

Poor sleep quality can occur as a result of sleep apnea or clinical depression. Poor sleep quality is caused by the individual not reaching stage 4 or delta sleep which has restorative properties. There are, however, people who are unable to achieve stage 4 sleep due to brain damage who lead perfectly normal lives.

Sleep apnea is a condition that occurs when a sleeping person's breathing is interrupted, thus interrupting the normal sleep cycle. With the obstructive form of the condition, some part of the sleeper's respiratory tract loses muscle tone and partially collapses. People with obstructive sleep apnea often do not remember awakening or having difficulty breathing, but they complain of excessive sleepiness during the day. Central sleep apnea interrupts the normal breathing stimulus of the central nervous system, and the individual must actually wake up to resume breathing. This form of apnea is often related to a cerebral vascular condition, congestive heart failure, and premature aging.

Major depression leads to alterations in the function of the hypothalamic-pituitary-adrenal axis, causing excessive release of cortisol which can lead to poor sleep quality.

Nocturnal polyuria, excessive nighttime urination, can be very disturbing to sleep.[16]

Treatment for insomnia

In many cases, insomnia is caused by another disease, side effects from medications or a psychological problem. It is important to identify or rule out medical and psychological before deciding on the treatment for the insomnia.[17] Attention to sleep hygiene is an important first line treatment strategy and should be tried before any pharmacological approach is considered.[18]

Non-pharmacological strategies

Non-pharmacological strategies are superior to hypnotic medication for insomnia because tolerance develops to the hypnotic effects as well as dependence can develop with rebound withdrawal effects developing upon discontinuation. Hypnotic medication is therefore only recommended for short term use. Non pharmacological strategies however, have long lasting improvements to insomnia and are recommended as a first line and long term strategy of managing insomnia. The strategies include attention to sleep hygiene, stimulus control, behavioral interventions, sleep-restriction therapy, patient education and relaxation therapy.[19]

Cognitive behavior therapy

A recent study found that cognitive behavior therapy is more effective than hypnotic medications in controlling insomnia.[citation needed] In this therapy, patients are taught improved sleep habits and relieved of counter-productive assumptions about sleep. Hypnotic medications are equally effective in the short term treatment of insomnia but their effects wear off over time due to tolerance. The effects of cognitive behavior therapy have sustained and lasting effects on treating insomnia long after therapy has been discontinued.[20][21] The addition of hypnotic medications with CBT adds no benefit in insomnia. The long lasting benefits of a course of CBT shows superiority over pharmacological hypnotic drugs. Even in the short term when compared to short term hypnotic medication such as zolpidem (Ambien), CBT still shows significant superiority. Thus CBT is recommended as a first line treatment for insomnia.[22]

Medications

Many insomniacs rely on sleeping tablets and other sedatives to get rest. All sedative drugs have the potential of causing psychological dependence where the individual cannot psychologically accept that they can sleep without drugs[citation needed]. Certain classes of sedatives such as benzodiazepines and newer nonbenzodiazepine drugs can also cause physical dependence which manifests in withdrawal symptoms if the drug is not carefully titrated down. The benzodiazepine and nonbenzodiazepine hypnotic medications also have a number of side effects such as day time fatigue, motor vehicle crashes, cognitive impairments and falls and fractures. Elderly people are more sensitive to these side effects.[23]

In comparing the options, a systematic review found that benzodiazepines and nonbenzodiazepines have similar efficacy which was not significantly more than for antidepressants.[24] Benzodiazepines did not have a significant tendency for more adverse drug reactions.[24] Chronic users of hypnotic medications for insomnia do not have better sleep than chronic insomniacs who do not take medications. In fact, chronic users of hypnotic medications actually have more regular nighttime awakenings than insomniacs who do not take hypnotic medications.[25] A further review of the literature regarding benzodiazepine hypnotic as well as the nonbenzodiazepines concluded that these drugs caused an unjustifiable risk to the individual and to public health and lack evidence of long term effectiveness. The risks include dependence, accidents and other adverse effects. Gradual discontinuation of hypnotics in long term users leads to improved health without worsening of sleep. Preferably hypnotics should be prescribed for only a few days at the lowest effective dose and avoided altogether wherever possible in the elderly.[26]

Benzodiazepines

The most commonly used class of hypnotics prescribed for insomnia are the benzodiazepines. Benzodiazepines bind unselectively to the GABAA receptor.[24] These include drugs such as temazepam, flunitrazepam, triazolam, flurazepam, midazolam, nitrazepam and quazepam. These drugs can lead to tolerance, physical dependence and the benzodiazepine withdrawal syndrome upon discontinuation, especially after consistent usage over long periods of time. Benzodiazepines while inducing unconsciousness, actually worsen sleep as they promote light sleep whilst decreasing time spent in deep sleep such as REM sleep.[27] A further problem is with regular use of short acting sleep aids for insomnia, day time rebound anxiety can emerge.[28]

Non-benzodiazepines

Nonbenzodiazepine sedative-hypnotic drugs, such as zolpidem, zaleplon, zopiclone and eszopiclone, are a newer classification of hypnotic medications. They work on the benzodiazepine site on the GABAA receptor complex similarly to the benzodiazepine class of drugs. Some but not all of the nonbenzodiazepines are selective for the α1 subunit on GABAA receptors which is responsible for inducing sleep and may therefore have a cleaner side effect profile than the older benzodiazepines. Zopiclone and eszopiclone like benzodiazepine drugs bind unselectively to α1, α2, α3 and α5 GABAA benzodiazepine receptors.[29] Zolpidem is more selective and zaleplon is highly selective for the α1 subunit, thus giving them an advantage over benzodiazepines in terms of sleep architecture and a reduction in side effects.[30][31] However, there are controversies over whether these non-benzodiazepine drugs are superior to benzodiazepines. These drugs appear to cause both psychological dependence and physical dependence though less than traditional benzodiazepines and can also cause the same memory and cognitive disturbances along with morning sedation.

Antidepressants

Some antidepressants such as amitriptyline, doxepin, mirtazapine, and trazodone can often have a very strong sedative effect, and are prescribed off label to treat insomnia. [32] The major drawback of these drugs is that they have antihistaminergic, anticholinergic and antiadrenergic properties which can lead to many side effects. Some also alter sleep architecture. As with many benzodiazepines, the use of antidepressants in the treatment of insomnia can lead to physical dependence; withdrawal may induce rebound insomnia and actually further complicate matters in the long-term.

Mirtazapine is known to decrease sleep latency, promoting sleep efficiency and increasing the total amount of sleeping time in patients suffering from both depression and insomnia [33] [34]

Melatonin and melatonin agonists

The hormone and supplement melatonin is effective in several types of insomnia. Melatonin has demonstrated effectiveness equivalent to the prescription sleeping tablet zopiclone in inducing sleep and regulating the sleep/waking cycle.[35] One particular benefit of melatonin is that it can treat insomnia without altering the sleep pattern which is altered by many prescription sleeping tablets. Another benefit is it does not impair performance related skills.[36][37]

Melatonin agonists, including ramelteon (Rozerem) and tasimelteon, seem to lack the potential for abuse and dependence. This class of drugs has a relatively mild side effect profile and lower likelihood of causing morning sedation. While these drugs show good effects for the treatment of insomnia due to jet lag,[38] the results for other forms of insomnia are less promising.[39]

Natural substances such as 5-HTP and L-Tryptophan have been said to fortify the serotonin-melatonin pathway and aid people with various sleep disorders including insomnia.[40]

Antihistamines

The antihistamine diphenhydramine is widely used in nonprescription sleep aids such as Tylenol PM®, with a 50 mg recommended dose mandated by the FDA. In the United Kingdom, Australia, New Zealand, South Africa, and other countries, a 25 mg to 50 mg recommended dose is permitted. While it is available over the counter, the effectiveness of these agents may decrease over time and the incidence of next-day sedation is higher than for most of the newer prescription drugs. Dependence does not seem to be an issue with this class of drugs.

Cyproheptadine is a useful alternative to benzodiazepine hypnotics in the treatment of insomnia. Cyproheptadine may be superior to benzodiazepines in the treatment of insomnia because cyproheptadine enhances sleep quality and quantity whereas benzodiazepines tend to decrease sleep quality.[41]

Atypical antipsychotics

Low doses of certain atypical antipsychotics such as quetiapine, olanzapine and risperidone are also prescribed for their sedative effect but the danger of neurological and cognitive side effects make these drugs a poor choice to treat insomnia. Over time, quetiapine may lose its effectiveness as a sedative. The ability of quetiapine to produce sedation is determined by the dosage. Higher doses (300 mg - 900 mg) are usually taken for its use as an antipsychotic, while lower doses (25 mg - 200 mg) have a marked sedative effect, e.g. if a patient takes 300 mg, he/she will more likely benefit from the drug's antipsychotic effects, but if the dose is brought down to 100 mg, it will leave the patient feeling more sedated than at 300 mg, because it primarily works as a sedative at lower doses.

Eplivanserin is an investigational drug with a mechanism similar to these antipsychotics, but probably with less side effects.

Other substances

Some insomniacs use herbs such as valerian, chamomile, lavender, hops, and passion-flower. Valerian has undergone multiple studies and appears to be modestly effective.[42][43][44] Cannabis has also been proven as an effective treatment for insomnia. [45]

Middle-of-the-night awakenings due to polyuria or other effects from alcohol consumption are common, hangovers can also lead to morning grogginess.

Insomnia may be a symptom of magnesium deficiency, or low magnesium levels, but this has not yet been proven. A healthy diet containing magnesium, can help to improve sleep in individuals without an adequate intake of magnesium.[46]

See also

References

  1. ^ Rowley, James A.; Nicholas Lorenzo (September 7, 2005). "Insomnia". eMedicine from WebMD. http://www.emedicine.com/neuro/TOPIC418.HTM#target10. Retrieved on 2008-08-04. "That insomnia is a symptom, not a disease, is important to note; ..." 
  2. ^ "WHO technical meeting on sleep and health" (pdf). http://www.euro.who.int/document/E84683_1.pdf. Retrieved on 2009-01-25.  "Dyssomnias" (pdf). WHO. 7-11. http://www.who.int/selection_medicines/committees/expert/17/application/Section24_GAD.pdf. Retrieved on 2009-01-25. 
  3. ^ "Brain Basics: Understanding Sleep: National Institute of Neurological Disorders and Stroke (NINDS)". http://www.ninds.nih.gov/disorders/brain_basics/understanding_sleep.htm. Retrieved on 2007-12-16. 
  4. ^ "Several Sleep Disorders Reflect Gender Differences". http://pn.psychiatryonline.org/cgi/content/full/42/10/40. Retrieved on 2008-09-05. 
  5. ^ a b Roth, Thomas; Timothy Roehrs (2004-02-25). "Insomnia: Epidemiology, characteristics, and consequences". Clinical Cornerstone 5 (3): 5–15. doi:10.1016/S1098-3597(03)90031-7. 
  6. ^ "Insomnia - sleeplessness, chronic insomnia, acute insomnia, mental ...". driectoryM articles. http://articles.directorym.com/Insomnia-a352.html. Retrieved on 2008-04-29. 
  7. ^ eMedicine - Sleep Disorders : Article by Curley L Bonds, MD
  8. ^ Lawrence KR, Adra M, Keir C (June 2006). "Hypoglycemia-induced anoxic brain injury possibly associated with levofloxacin". J. Infect. 52 (6): e177–80. doi:10.1016/j.jinf.2005.08.024. PMID 16269178. 
  9. ^ Douma, S.L, Husband, C., O’Donnell, M.E., Barwin, B.N., Woodend A.K. (2005). "Estrogen-related Mood Disorders Reproductive Life Cycle Factors". Advances in Nursing Science 28 (4): 364–375. PMID 16292022. 
  10. ^ Lasiuk, GC and Hegadoren, KM (2007). "The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women". Biological Research for Nursing (2007), 9 (2): 147–160. doi:10.1177/1099800407305600. PMID 17909167. 
  11. ^ a b Mendelson WB (2008). "New Research on Insomnia: Sleep Disorders May Precede or Exacerbate Psychiatric Conditions". Psychiatric Times 25 (7). http://www.psychiatrictimes.com/insomnia/article/10168/1163082. 
  12. ^ American Family Physician: Chronic Insomnia: A Practical Review
  13. ^ a b "2002 Sleep in America Poll". National Sleep Foundation. http://www.sleepfoundation.org/site/c.huIXKjM0IxF/b.2417355/k.143E/2002_Sleep_in_America_Poll.htm. Retrieved on 2008-08-13. 
  14. ^ Mayo Clinic > Insomnia > Complications By Mayo Clinic staff. Retrieved on May, 5, 2009
  15. ^ Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (February 2002). "Mortality associated with sleep duration and insomnia". Arch. Gen. Psychiatry 59 (2): 131–6. PMID 11825133. http://archpsyc.ama-assn.org/cgi/content/full/59/2/131. 
  16. ^ Sleep issues in Parkinson’s disease. Neurology. 2005. pp. 64; S12–20. http://www.neurology.org/cgi/content/full/64/12_suppl_3/S12. 
  17. ^ Wortelboer U, Cohrs S, Rodenbeck A, Rüther E (2002). "Tolerability of hypnosedatives in older patients". Drugs Aging 19 (7): 529–39. doi:10.2165/00002512-200219070-00006. PMID 12182689. 
  18. ^ Flamer HE (June 1995). "Sleep problems". Med. J. Aust. 162 (11): 603–7. PMID 7791648. 
  19. ^ Kirkwood CK (1999). "Management of insomnia". J Am Pharm Assoc 39 (5): 688–96; quiz 713–4. PMID 10533351. 
  20. ^ Jacobs, Gregg; Edward F. Pace-Schott, Robert Stickgold, Michael W. Otto (September 27, 2004). "Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: A Randomized Controlled Trial and Direct Comparison". Archives of Internal Medicine 164 (17): 1888–1896. doi:10.1001/archinte.164.17.1888. PMID 15451764. http://archinte.ama-assn.org/cgi/content/full/164/17/1888?ijkey=6a2af558a671b089d7c77db5fc5f53a450fd1cda. 
  21. ^ Morin, C. M. (1999). "Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial". JAMA the Journal of the American Medical Association 281: 991. doi:10.1001/jama.281.11.991. PMID 10086433. http://jama.ama-assn.org/cgi/content/full/281/11/991. 
  22. ^ KARL E. MILLER, M.D. (July 2005). "Cognitive Behavior Therapy vs. Pharmacotherapy for Insomnia". American Family Physician. http://www.aafp.org/afp/20050715/tips/7.html. 
  23. ^ Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE (November 2005). "Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits". BMJ 331 (7526): 1169. doi:10.1136/bmj.38623.768588.47. PMID 16284208. PMC: 1285093. http://www.bmj.com/cgi/content/full/331/7526/1169. 
  24. ^ a b c Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M. (September 2007). "The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs". J Gen Intern Med 22 (9): 1335–1350. doi:10.1007/s11606-007-0251-z. PMID 17619935. 
  25. ^ Ohayon MM, Caulet M (May 1995). "Insomnia and psychotropic drug consumption". Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (3): 421–31. doi:10.1016/0278-5846(94)00023-B. PMID 7624493. http://linkinghub.elsevier.com/retrieve/pii/027858469400023B. 
  26. ^ "What's wrong with prescribing hypnotics?". Drug Ther Bull 42 (12): 89–93. December 2004. doi:10.1136/dtb.2004.421289. PMID 15587763. http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Drug-Class-Focused-Reviews/498264/. 
  27. ^ Tsoi, Wf (Mar 1991). "Insomnia: drug treatment.". Annals of the Academy of Medicine, Singapore 20 (2): 269–72. ISSN 0304-4602. PMID 1679317. 
  28. ^ Montplaisir J (August 2000). "Treatment of primary insomnia" (PDF). CMAJ 163 (4): 389–91. PMID 10976252. PMC: 80369. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=10976252. 
  29. ^ WHO (2006). "World Health Organisation - Assessment of Zopiclone" (PDF). who.int. http://www.who.int/medicines/areas/quality_safety/4.6ZopicloneCritReview.pdf. 
  30. ^ Rowlett JK, Woolverton WL (November 1996). "Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies". Psychopharmacology (Berl.) 128 (1): 1–16. doi:10.1007/s002130050103. PMID 8944400. http://www.springerlink.com/content/xeu44evyanvw1n65/fulltext.pdf. 
  31. ^ Noguchi H; Kitazumi K, Mori M, Shiba T. (March 2004). "Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats" (pdf). J Pharmacol Sci. 94 (3): 246–51. doi:10.1254/jphs.94.246. PMID 15037809. http://www.jstage.jst.go.jp/article/jphs/94/3/246/_pdf. 
  32. ^ Bertschy G, Ragama-Pardos E, Muscionico M, et al (January 2005). "Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study". Pharmacol. Res. 51 (1): 79–84. doi:10.1016/j.phrs.2004.06.007. PMID 15519538. 
  33. ^ Winokur A, DeMartinis NA 3rd, McNally DP, Gary EM, Cormier JL, Gary KA. , et al (August url=http://www.ncbi.nlm.nih.gov/pubmed/14658972?ordinalpos=30&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum). "Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia". J Clin Psychiatry year=2003. 
  34. ^ Schittecatte M, Dumont F, Machowski R, Cornil C, Lavergne F, Wilmotte J , et al. "Effects of mirtazapine on sleep polygraphic variables in major depression". Neuropsychobiology year=2002 url=http://www.ncbi.nlm.nih.gov/pubmed/12566938?ordinalpos=62&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum. 
  35. ^ Paul MA, Gray G, Sardana TM, Pigeau RA (May 2004). "Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews". Aviat Space Environ Med 75 (5): 439–43. PMID 15152897. 
  36. ^ Paul MA, Gray G, Kenny G, Pigeau RA (December 2003). "Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance". Aviat Space Environ Med 74 (12): 1263–70. PMID 14692469. 
  37. ^ Zhdanova IV, Tucci V (May 2003). "Melatonin, Circadian Rhythms, and Sleep" ([dead link]Scholar search). Curr Treat Options Neurol 5 (3): 225–229. doi:10.1007/s11940-003-0013-0. PMID 12670411. http://www.treatment-options.com/1092-8480/5/225. 
  38. ^ Rajaratnam, SMW; Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB (2 December 2008). "Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials". Lancet 373: 482. doi:10.1016/S0140-6736(08)61812-7. 
  39. ^ Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T (August 2007). "Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia". J Clin Sleep Med 3 (5): 495–504. PMID 17803013. 
  40. ^ Morton Walker, DPM - The Restoration of L-Tryptophan with Its Numerous Physiological Benefits
  41. ^ Tokunaga S; Takeda Y, Shinomiya K, Hirase M, Kamei C. (February 2007). "Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats" (pdf). J Pharmacol Sci. 103 (2): 201–6. doi:10.1254/jphs.FP0061173. PMID 17287588. http://www.jstage.jst.go.jp/article/jphs/103/2/201/_pdf. 
  42. ^ Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I (2000). "Critical evaluation of the effect of valerian extract on sleep structure and sleep quality". Pharmacopsychiatry 33 (2): 47–53. doi:10.1055/s-2000-7972. PMID 10761819. 
  43. ^ Morin CM, Koetter U, Bastien C, Ware JC, Wooten V (2005). "Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial". Sleep 28 (11): 1465–71. PMID 16335333. 
  44. ^ Meolie AL, Rosen C, Kristo D, et al (2005). "Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence". Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 1 (2): 173–87. PMID 17561634. 
  45. ^ http://www.cannabis.net/medical-marijuana/pot-docs.html
  46. ^ Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1998). "Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study". Sleep 21 (5): 501–5. PMID 9703590. 


Wiktionary

Up to date as of January 15, 2010

Definition from Wiktionary, a free dictionary

Contents

English

Pronunciation

Wikipedia-logo.png
Wikipedia has an article on:

Wikipedia

Noun

Singular
insomnia

Plural
uncountable

insomnia (uncountable)

  1. a sleeping disorder that is known for its symptoms of unrest and the inability to sleep

Derived terms

Translations


Simple English

Insomnia is when people can not sleep. A person suffering from this disorder is called an insomniac. Insomnia can mean a problem with getting to sleep or a problem with staying asleep. Insomnia is a symptom and not a disease or illness.[1]

Contents

Causes for Insomnia

There can be many causes for insomnia. Some of them are:

  • As people get older, their sleep patterns change. They will sleep shorter periods of time, but more often. Younger people usually sleep longer. This is normal.
  • Some insomnias are caused by real-world causes. Coffee stimulates the body, and people tend to drink quite a lot of it when they are at work. If they drink too much of it, they will have problems falling asleep in the evening. (The same is true for tea, colas, or any other drink with caffeine in it.)
  • Some people worry a lot. Their worries during the day will bother them at night. They might have nightmares, or they wake up sweating.
  • Some substances, like alcohol can have a bad effect. It can be very hard to sleep after drinking a lot of alcohol. The world may spin and there can be an urge to vomit as soon the person closes their eyes. Drugs can also have this effect, even some "sleeping" pills.
  • A very rare disease called fatal familial insomnia prevents some people from falling asleep. In this disease, a person can no longer sleep and after a while will die from being so tired. It is caused by a protein similar to the one that causes mad cow disease which is a very bad disease that comes from eating bad meat.
  • People with disorders of their circadian rhythms often have trouble sleeping at normal times.

Different kinds of insomnia

There are at least three different types of insomnia:

  1. Transient Insomnia: this lasts from one night to a few weeks.
  2. Acute Insomnia: lasts from a few weeks to about six months.
  3. Chronic Insomnia: lasts for years at a time.

Treating insomnia

There are drugs available that can help treat the different kinds of insomnia. There are also certain herbs that can help, in some cases. A third way that seems to help is a therapy that aims at changing the behaviour of those affected.

References

  1. Hirshkowitz, Max (2004). "Chapter 10, Neuropsychiatric Aspects of Sleep and Sleep Disorders (pp 315-340)". In Stuart C. Yudofsky and Robert E. Hales, editors (Google Books preview includes entire chapter 10). Essentials of neuropsychiatry and clinical neurosciences (4 ed.). Arlington, Virginia, USA: American Psychiatric Publishing. ISBN 9781585620050. http://books.google.no/books?id=XKhu7yb3QtsC&pg=PA315&lpg=PA315&dq=%22Max+Hirshkowitz%22&source=bl&ots=Rt5ZMiMbxt&sig=7upt8PudAdiA5f9kk5KGsrfaMQU&hl=no&ei=y-0bS7vFKtTP-QabhdTaDw&sa=X&oi=book_result&ct=result&resnum=3&ved=0CBIQ6AEwAjgK#v=onepage&q=%22Max%20Hirshkowitz%22&f=false. Retrieved 2009-12-06. "...insomnia is a symptom. It is neither a disease nor a specific condition. (from p. 322)" 








Got something to say? Make a comment.
Your name
Your email address
Message